Beyond Bone Density: How Fracture Risk Is Changing Osteoporosis Management

• by

• July 8, 2026

Population-scale reconstruction of menopause dynamics reveals a physiological cliff at the final menstrual period

• by Glen Pridham, Yoav Hayut, Noa Lavi-Shoseyov, Michal Neeman, Noa Hovav, Yoel Toledano, Uri Alon

• October 12, 2026

Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs Do Not Arrest Bone Loss in Patients With Rheumatoid Arthritis: A Long-Term Multicenter Observational Study

• by Takafumi Aritomi, Koshiro Sonomoto, Shingo Nakayamada, Hiroaki Tanaka, Atsushi Nagayasu, Satoshi Kubo, Ippei Miyagawa, Ayako Yamaguchi, Naoaki Ohkubo, Yasuyuki Todoroki, Yurie Satoh-Kanda, Masanobu Ueno, Ryuichiro Kanda, Yuya Fujita, Masashi Funada, Hidenori Sakai, Satsuki Matsunaga, Masayuki Shinojima, Hiroki Kawamura, Kazuki Takahashi, Miyabi Ando, Kazuki Haru, Yusuke Miyazaki, Kentaro Hanami, Masao Nawata, Shunsuke Fukuyo, Keisuke Nakatsuka, Mikiko Tokunaga, Kazuyoshi Saito, Yoshiya Tanaka

• April 21, 2026

IOPTH Widely Used, Variation Persists

Most surgeons reported using intraoperative parathyroid hormone monitoring, but approaches to imaging and intraoperative criteria varied, particularly in secondary and tertiary disease

• by Kathryn Wighton

• April 13, 2026

• 3 min